ENvue Medical, Inc. (FEED)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 500K 1M 1.5M Q2 '21: 318K Q3 '21: 499K Q4 '21: 775K Q1 '22: 272K Q2 '22: 485K Q3 '22: 97K Q1 '23: 354K Q2 '23: 294K Q3 '23: 458K Q4 '23: 1.2M Q1 '24: 921K Q2 '24: 817K Q3 '24: 376K Q4 '24: 444K Q1 '25: 1M Q2 '25: 494K Q3 '25: 722K Q4 '25: 312K Q1 '26: 653K Q2 '26: 239K Q3 '21 Q2 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Gross Profit Quarterly

-600K -300K 0 300K 600K 900K Q2 '21: 208K Q3 '21: 228K Q4 '21: 257K Q1 '22: 106K Q2 '22: 281K Q3 '22: 80K Q1 '23: 235K Q2 '23: 216K Q3 '23: 349K Q4 '23: 737K Q1 '24: 664K Q2 '24: 428K Q3 '24: 133K Q4 '24: 283K Q1 '25: 369K Q2 '25: -35K Q3 '25: 189K Q4 '25: -370K Q1 '26: -55K Q2 '26: -266K Q3 '21 Q2 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Income Quarterly

-18M -12M -6M 0 6M 12M 18M Q3 '21: -868K Q4 '21: -2.5M Q1 '22: -1.1M Q2 '22: -1.3M Q3 '22: -924K Q4 '22: -1.7M Q1 '23: -1.1M Q2 '23: -1M Q3 '23: -670K Q4 '23: -702K Q1 '24: -568K Q2 '24: -674K Q3 '24: -970K Q4 '24: -1.4M Q1 '25: -1.9M Q2 '25: -4M Q3 '25: -2.2M Q4 '25: -14.8M Q1 '26: -3.7M Q2 '26: -5.5M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-15M -10M -5M 0 5M 10M 15M Q3 '21: -6.7M Q4 '21: -2.5M Q1 '22: -1.1M Q2 '22: -1.3M Q3 '22: -955K Q4 '22: -2.1M Q1 '23: -1.1M Q2 '23: -1.1M Q3 '23: -727K Q4 '23: -813K Q1 '24: -588K Q2 '24: -688K Q3 '24: -998K Q4 '24: -1.4M Q1 '25: -1.9M Q2 '25: -4M Q3 '25: 510K Q4 '25: -12.9M Q1 '26: -3.8M Q2 '26: -4.9M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

0 250K 500K 750K Q3 '21: 271K Q4 '21: 518K Q1 '22: 166K Q2 '22: 204K Q3 '22: 17K Q4 '22: 198K Q1 '23: 119K Q2 '23: 78K Q3 '23: 109K Q4 '23: 440K Q1 '24: 257K Q2 '24: 389K Q3 '24: 243K Q4 '24: 161K Q1 '25: 656K Q2 '25: 529K Q3 '25: 533K Q4 '25: 682K Q1 '26: 708K Q2 '26: 505K Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating Cash Flow Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q3 '21: -634K Q4 '21: -863K Q1 '22: -1.7M Q2 '22: -2M Q3 '22: -2M Q4 '22: -1.3M Q1 '23: -1.2M Q2 '23: -1.2M Q3 '23: -682K Q4 '23: -491K Q1 '24: -579K Q2 '24: -553K Q3 '24: -836K Q4 '24: -548K Q1 '25: -1.3M Q2 '25: -3.4M Q3 '25: -2M Q4 '25: -2.7M Q1 '26: -4.3M Q2 '26: -2.7M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-4.5M -3M -1.5M 0 1.5M 3M 4.5M Q4 '18: -881K Q1 '21: -956K Q2 '21: -1.9M Q3 '21: -635K Q4 '21: -863K Q3 '22: -2M Q1 '23: -1.2M Q2 '23: -1.2M Q3 '23: -682K Q4 '23: -491K Q1 '24: -580K Q2 '24: -555K Q3 '24: -836K Q4 '24: -548K Q1 '25: -1.3M Q2 '25: -3.4M Q3 '25: -2M Q4 '25: -2.7M Q1 '26: -4.3M Q2 '26: -2.7M Q1 '21 Q4 '21 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 9M 18M 27M Q1 '21: 24.2M Q2 '21: 24.8M Q3 '21: 26.1M Q1 '22: 1.4M Q2 '22: 1.4M Q3 '22: 1.4M Q1 '23: 1.7M Q2 '23: 1.7M Q3 '23: 1.7M Q1 '24: 247K Q2 '24: 25.3K Q3 '24: 280.3K Q1 '25: 62.6K Q2 '25: 484.6K Q3 '25: 858.4K Q1 '26: 3.3M Q2 '26: 6.2M Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-210.00 -140.00 -70.00 0.00 70.00 140.00 210.00 Q2 '20: -0.62 Q3 '20: -0.60 Q4 '20: -0.42 Q1 '21: -0.49 Q2 '21: -0.30 Q3 '21: -0.46 Q4 '21: -0.57 Q1 '22: -1.18 Q2 '22: -2.10 Q3 '22: -2.52 Q4 '22: -3.84 Q1 '23: -3.70 Q2 '23: -3.42 Q3 '23: -3.16 Q4 '23: -23.33 Q1 '24: -20.28 Q2 '24: -46.81 Q3 '24: -49.95 Q4 '24: -157.28 Q1 '25: -189.56 Q3 '20 Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.